BioCrossroads launches hub for life sciences news

INDIANAPOLIS, July 11, 2017 — BioCrossroads today announced its agenda for the 2017 Indiana Life Sciences Summit. The Summit kicks off on Mon. Oct. 9 with an expanded scientific session, the New Venture Competition Winner announcement, a poster session and the Cook Medical and Eli Lilly and Company Networking Reception.

The speaker line up for both days includes TED-like talks from Ken Payie with Mapp Biopharmaceutical Inc., which develops novel monoclonal antibodies for the treatment of infectious diseases, focusing on unmet needs in global health and biodefense, such as an antibody treatment for Ebola-Zaire; June Wasser from the Reagan-Udall Foundation for the FDA, a non-profit that assists in the creation of new, applied scientific knowledge, tools, standards and approaches the FDA needs to evaluate products more effectively, predictably and efficiently; Dr. Marcus Wilson Pharm.D., President, HealthCore, who will discuss accelerating medical evidence development; and other international and national thought leaders.

Additional speeches and presentations will cover the topics of immunology, global health, capital formation, innovation models and more.

The Summit will take place at the JW Marriott, downtown Indianapolis.  Sponsors of the conference include Cook Medical, Eli Lilly and Company, Faegre Baker Daniels, and Roche Diagnostics.

More information and registration are available at

In other news, BioCrossroads has launched, a hub for life sciences company news and event announcements. The site will categorize life sciences news by people, company news, research news and start-up news.  Submissions must have both an Indiana connection and a life sciences focus.

“Indiana’s life sciences innovation and research continues its strong position with the second highest number of exports in the U.S. and a $63 billion impact on the economy,” said Lori LeRoy, vice president of communications, BioCrossroads.  “We wanted to create a centralized location that showcases our life sciences activity in one place and promote the efforts of our 1,700 companies, 56,000 employees and university R&D.”

 About BioCrossroads

BioCrossroads ( is Indiana’s initiative to grow, advance and invest in the life sciences, a public-private collaboration that supports the region’s existing research and corporate strengths while encouraging new business development.  BioCrossroads provides money and support to life sciences businesses, launches new life sciences enterprises (Indiana Biosciences Research Institute, Indiana Health Information Exchange, Fairbanks Institute for Healthy Communities, BioCrossroadsLINX, OrthoWorx and Datalys Center), expands collaboration and partnerships among Indiana’s life science institutions, promotes science education and markets Indiana’s life sciences industry.